Curcumin Prevents Epithelial-to Mesenchymal Transition-Mediated Ovarian Cancer Progression through NRF2/ETBR/ET-1 Axis and Preserves Mitochondria Biogenesis in Kidney after Cisplatin Administration.

Barinda AJ, Arozal W, Sandhiutami NMD, Louisa M, Arfian N, Sandora N, Yusuf M

Open source

DOI
10.34172/apb.2022.014
Published
2022 Jan
Container
Advanced pharmaceutical bulletin
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.34172/apb.2022.014,
  title = {Curcumin Prevents Epithelial-to Mesenchymal Transition-Mediated Ovarian Cancer Progression through NRF2/ETBR/ET-1 Axis and Preserves Mitochondria Biogenesis in Kidney after Cisplatin Administration.},
  author = {Barinda AJ and Arozal W and Sandhiutami NMD and Louisa M and Arfian N and Sandora N and Yusuf M},
  year = {2022},
  journal = {Advanced pharmaceutical bulletin},
  doi = {10.34172/apb.2022.014},
  url = {https://doi.org/10.34172/apb.2022.014}
}

RIS

TY  - JOUR
TI  - Curcumin Prevents Epithelial-to Mesenchymal Transition-Mediated Ovarian Cancer Progression through NRF2/ETBR/ET-1 Axis and Preserves Mitochondria Biogenesis in Kidney after Cisplatin Administration.
AU  - Barinda AJ
AU  - Arozal W
AU  - Sandhiutami NMD
AU  - Louisa M
AU  - Arfian N
AU  - Sandora N
AU  - Yusuf M
PY  - 2022
JO  - Advanced pharmaceutical bulletin
DO  - 10.34172/apb.2022.014
UR  - https://doi.org/10.34172/apb.2022.014
ER  - 

APA

AJ, B., W, A., NMD, S., M, L., N, A., N, S., & M, Y. (2022). Curcumin Prevents Epithelial-to Mesenchymal Transition-Mediated Ovarian Cancer Progression through NRF2/ETBR/ET-1 Axis and Preserves Mitochondria Biogenesis in Kidney after Cisplatin Administration.. Advanced pharmaceutical bulletin. https://doi.org/10.34172/apb.2022.014

Source records